PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas. - Wikidata - wikimedia - TriplyDB

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

http://www.wikidata.org/entity/Q35606891

about

Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma MicroRNA miR-155 is a biomarker of early pancreatic neoplasia Genetics and biology of pancreatic ductal adenocarcinoma Oncogenic mutations of PIK3CA in human cancers Insights into the Pathogenesis of Pancreatic Cystic Neoplasms.Pancreatic cancer.Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.PIK3CA mutations in mucinous cystic neoplasms of the pancreas.Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.Genomic landscapes of pancreatic neoplasia.Cystic precursors to invasive pancreatic cancer.BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas.PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors Precursors to pancreatic cancer.PIK3CA polymorphisms associated with susceptibility to hepatocellular carcinoma.Targeting signal transduction in pancreatic cancer treatment.Pancreatic carcinogenesis Emerging molecular biology of pancreatic cancer.The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting.Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.Hypermethylation-mediated reduction of WWOX expression in intraductal papillary mucinous neoplasms of the pancreas.Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.A modular and flexible ESC-based mouse model of pancreatic cancer.A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes.Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas.Metabolism addiction in pancreatic cancer.

P2860

Q21129230-3DE5C6F5-D5D3-4AA2-8774-67847FB133D0 Q24649254-C2EA75EF-477F-4816-BEEA-77F8A36DA250 Q26765438-ECF0084C-65BE-4645-91F0-4A9CD7841642 Q28284802-E4D91333-CEC5-4244-91F9-AB8BDA02643F Q30234478-0FDFC166-1487-42EA-8B74-EE534CA49819 Q30490247-29A1DE9B-5851-4E9E-8FC2-DE21800DED5A Q30504615-579B7222-B6C8-4F41-B5C5-D607E95DC41E Q33754040-4E0E8F02-4EE1-4B4E-AF00-A75044526E95 Q33790925-EA6725FF-019C-4BF3-B010-7D8C2D28D369 Q33911620-A8E826EE-E0C9-4190-A7A2-91B00292E20B Q33942405-EF0BE605-8440-415A-ABC8-C7EC40623523 Q34008627-436FCCCE-0F67-4D25-8FB9-38ACC4F88B92 Q34330763-2C29CA23-0DD8-451E-A0A3-4EB191E99D1E Q34635042-023AD485-BF69-4BB7-A7F8-7B009D3006E8 Q34657038-076D8DE1-DB03-4461-914D-850E8161067C Q35123631-CF747DCA-34B8-4732-86C3-287AE53F4F6B Q35170720-7D30ABDD-C7C8-497B-8CB3-2CB9B4627415 Q35609914-4C9BBCA4-329F-41D0-8C5E-34AF6E540396 Q35783104-CD2048F0-C4A0-4555-9BD0-C9A8D11D8732 Q36221363-01F26C98-9740-4598-94DD-A32C8322241F Q36245945-96D96FE6-2C05-4CB1-919D-B7E652BB5A37 Q36372625-7D560099-DD27-45D3-AF54-3ADF00C0FF5B Q36464954-FC160A54-6B30-47BC-BEE4-A16B46A7DE2F Q36804444-014520CC-CF9F-408B-8611-BCF444178539 Q37125627-C697851B-FAB0-42B3-88E2-75FE02BBC8F4 Q37141651-DA15FD1F-33B1-4BBE-9004-0E2CFF64FE09 Q37156381-BCD2A025-C241-4573-A508-996ACC2E2D6D Q37176648-F9EDF4AD-5A5D-4465-A981-9E3464837263 Q37183611-96C57A08-7AB2-421F-B627-7A886CD426FE Q37222620-1D7C017F-1AC1-40F9-A830-0F945CAB6450 Q37291172-D1124450-515D-4551-90E2-3F9243574063 Q37411831-1C5B221A-7D74-4A06-8F2C-DBE115D4CDB8 Q37454384-236374AE-6A27-40ED-B333-A919CEC4D9AD Q37474182-B96956F1-F5FD-4500-ABDA-F5D0E83E99BA Q37488746-01CF4EB9-F8EF-4C37-B286-D973614C49EA Q37549140-95AC42B4-5BB4-4BA1-A4FF-7DC3DB2F5F1D Q37558614-4DB54543-A687-458A-8BD4-7F65EF62A0A7 Q37558621-57BF8DEF-9F79-4BDF-93BD-E5C893DFBD0B Q37558631-A6FBB0FB-94F9-439B-8506-2D7CAB0B34B6 Q37620679-1FABBA4C-20F2-4767-BB3D-8F8B8496675A

P2860

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

http://www.wikidata.org/entity/Q35606891

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

@ast

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

@en

type

label

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

@ast

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

@en

prefLabel

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

@ast

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

@en

P1433

Q35606891-64F510F9-98AA-4070-BDC3-FCF6EFB37C84

P1476

Q35606891-5D838EFF-A962-4D2D-AB5B-AD517F8F0ECD

P2093

Q35606891-1C0E82C0-632F-499C-90A8-9A023E112E58

Q35606891-25E0B285-1B3C-44F5-9326-460DA2905BD1

Q35606891-6DC50D57-4412-411E-9AB8-43AA0D18F40E

Q35606891-7E1B1DE1-57C6-4B06-870A-D93BBE25D25B

Q35606891-84D39A4C-428E-4453-B522-8C3A6269A03B

Q35606891-C6014153-52E2-4B57-A3FA-4911B0A2C1B3

Q35606891-C6F37936-0043-44E2-BC20-0C9BB6957489

Q35606891-C7DB4E44-5527-4D61-8D64-B9D7F850F1CF

P2860

Q35606891-00728DB5-4BF2-427D-B8EB-EBEBDB1018CF

Q35606891-0201DD8F-0B7C-4D1E-B15A-A4910D753AD6

Q35606891-032D74F4-1037-4A4C-9E08-88FAEFB73B24

Q35606891-0DB18B4A-159B-4A64-A864-E360C9C8E0CD

Q35606891-10CBAF9B-AAE0-441F-B36E-D91B6F21A624

Q35606891-16AD1AB9-35F0-44F3-99E2-492009249CAC

Q35606891-1A4E1868-8B7C-4B11-8F00-BC238FB118AE

Q35606891-262097C1-0457-4222-B167-6CF0200DD419

Q35606891-2756E50D-3D0F-4E28-A132-0A78CF1A35FF

Q35606891-2E5267A8-8EA9-438F-947F-A7F29B0D5494

P304

Q35606891-2D0571B0-4F1B-464E-91BF-B88AAFD09BC9

P31

Q35606891-C0EF01F0-E0E4-4BF8-B631-FCB0703135B2

P356

Q35606891-41B8E9BC-1548-48EF-9852-483B67CB49B4

P407

Q35606891-D2919A69-6C7E-4779-98D8-9D34AC7C975A

P433

Q35606891-25ECDBB7-0EDF-4479-A80B-70D74A816DCD

P478

Q35606891-6CF08EC2-12F0-4E93-AA11-60BC1E886653

P577

Q35606891-EE9B7F5A-68B1-4AD4-8904-2321613099BF

P698

Q35606891-F679F0CB-27D7-429A-AD67-AF8097EA6D99

P921

Q35606891-CE56C807-67F5-40F6-A25F-6056F581A7FD

P932

Q35606891-A031952E-DAD8-461F-AB82-2B260FBFFEA3

P356

1078-0432.CCR-06-0292

P1433

Clinical Cancer Research

P1476

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.

@en

P2093

Daniel J Ho

http://www.w3.org/2001/XMLSchema#string

Frank Schönleben

http://www.w3.org/2001/XMLSchema#string

Gloria H Su

http://www.w3.org/2001/XMLSchema#string

Helen E Remotti

http://www.w3.org/2001/XMLSchema#string

John D Allendorf

http://www.w3.org/2001/XMLSchema#string

Nancy T Ciau

http://www.w3.org/2001/XMLSchema#string

Wanglong Qiu

http://www.w3.org/2001/XMLSchema#string

Xiaojun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of PIK3CA in gastric adenocarcinoma

Purification and characterization of phosphoinositide 3-kinase from rat liver

The PI3K-PDK1 connection: more than just a road to PKB

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience

Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation

Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers

STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

High frequency of mutations of the PIK3CA gene in human cancers

Signaling by distinct classes of phosphoinositide 3-kinases

P304

3851-3855

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-06-0292

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16778113

http://www.w3.org/2001/XMLSchema#string

P921

Aizkuņģa dziedzeris

P932

1780026

http://www.w3.org/2001/XMLSchema#string